REBUTTAL TO AN ARTICLE IN THE PRESS:
https://illinoisnewstoday.com/ivermectin-causes-sterilization-in-85-percent-of-men-studies-find/367625/1. The article headline: ivermectin causes sterilization in 85 percent of men studies find
Studies - They quote a SINGLE study
2. Non - RCT study, in other words: NO CONTROL is used in the study.
Why would this be a problem? WOLBACHIA bacteria on which the adult worms of the Onchocerca volvulus parasite depends is known to CHANGE THE SEX OF INFECTED HOSTS IN OTHER SPECIES. So this bacteria is known to mess with sexual reproduction systems. There is NO control in the study ergo it is NOT a Randomized Control Trial (RCT):
a. You are not controlling for the effects that the disease may be having naturally.
b. Have any studies been undertaken for the effects of river blindness on men's reproductive systems?
3. Size of study - 37 patients only
This is significant because: Ivermectin use for COVID19 is criticized for lack of the size of the efficacy studies. Although there are:
63 studies, involving 26 422 patients and 613 scientists.
31 RCT studies involving 6 561 patients and 359 scientists.
The results:
86% improvement when used prophelactically
69% improvement in early treatment
40% improvement in late treatment
4. Dosage: In the study Ivermectin was prescribed for 11 months of continuous use at 150µg/kg per day.
Let that sink in: 330 DAYS OF CONTINUOUS USE.
Ivermectin recommendation usage as prophelaxis: 1 dose every two weeks!
5. The "journal" where the study was published: Archives of Applied Science Research does not require submission charges, but study authors are required to pay a “fair handling fee for processing their articles” of up to 1000 euros.
6. The study does not include any section on limitations. Limitations are important for other scientists to understand the context of study findings to interpret the validity of the scientific work.
